Nordic Biological Specimen Bank Cohorts as Basis for Studies of Cancer Causes and Control: Quality Control Tools for Study Cohorts with More than Two Million Sample Donors and 130,000 Prospective Cancers

Methods in Molecular Biology

Volumn 675, Issue , 2011, Pages 61-112

  Pukkala, Eero ^a,b  

^a FINNISH CANCER REGISTRY   (Finland)

^b UNIVERSITY OF TAMPERE   (Finland)

Author keywords

Biobanks; Cancer incidence; Cohort study; Control selection; Inverse causality; Record linkage; Selection bias

Indexed keywords

ADULT; BIOBANK; CALCULATION; CANCER INCIDENCE; CANCER RISK; CASE CONTROL STUDY; CAUSALITY; COHORT ANALYSIS; CONTROLLED STUDY; DATA QUALITY; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PREDICTION; PROSPECTIVE STUDY; QUALITY CONTROL; SELECTION BIAS; STANDARDIZED INCIDENCE RATIO; ARTICLE; DONOR; HEALTH CARE FACILITY; NEOPLASM; STANDARD;

BIOLOGICAL SPECIMEN BANKS; COHORT STUDIES; HUMANS; NEOPLASMS; TISSUE DONORS;

EID: 79952116114     PISSN: 10643745     EISSN: 19406029     Source Type: Book Series    
DOI: 10.1007/978-1-59745-423-0_3     Document Type: Chapter

References (57)

1. Dillner, J., Knekt, P., Schiller, J.T. and Hakulinen, T.: Prospective seroepidemiological evidence that Human Papillomavirus type 16 infection is a risk factor for oesophageal squamous cell carcinoma. Br. Med. J. 311: 1346 (1995)
2. Lehtinen, M., Dillner, J., Knekt, P., Luostarinen, T., Aromaa, A., Kirnbauer, R., Koskela, P., Paavonen, J., Peto, R., Schiller, J.T. and Hakama, M.: Serologically diagnosed infection with human papillomavirus type 16 and risk for subsequent development of cervical carcinoma: nested case-control study. Br. Med. J. 312: 537–539 (1996)
3. Lehtinen, T., Luostarinen, T., Dillner, J., Aromaa, A., Hakama, M., Hakulinen, T., Knekt, P., Leinikki, P., Lumio, J., Lähdeaho, M.-L., Maatela, J., Teppo, L. and Lehtinen, M.: Serum p53 accumulation and altered antibody responses to Epstein-Barr virus proteins precede diagnosis of haemopoietic malignancies of lymphoid origin. Br. J. Haematol. 93: 104–110 (1996)
4. Dillner, J., Kallings, I., Brihmer, C., Sikström, B., Koskela, P., Lehtinen, M., Schiller, J.T., Sapp, M. and Mårdh, P.A.: Seropositivities to Human Papillomavirus type 16, 18, or 33 capsids and to Chlamydia trachomatis are markers of sexual behavior. J. Infect. Dis. 173: 1394–1398 (1996)
5. Bjørge, T., Dillner, J., Anttila, T., Engeland, A., Hakulinen, T., Jellum, E., Lehtinen, M., Luostarinen, T., Paavonen, J., Pukkala, E., Sapp, M., Schiller, J., Youngman, L. and Thoresen, S.: Prospective seroepidemiological study of role of human papillomavirus in non-cervical anogenital cancers. Br. Med. J. 315: 646–649 (1997)
6. Dillner, J., Lehtinen, M., Bjørge, T., Luostarinen, T., Youngman, L., Jellum, E., Koskela, P., Gislefoss, R.E., Hallmans, G., Paavonen, J., Sapp, M., Schiller, J.T., Hakulinen, T., Thoresen, S. and Hakama, M.: Prospective seroepidemiologic study of human papillomavirus infection as a risk factor for invasive cervical cancer. J. Natl. Cancer Inst. 89: 1293–1299 (1997)
7. Bjørge, T., Hakulinen, T., Engeland, A., Jellum, E., Koskela, P., Lehtinen, M., Luostarinen, T., Paavonen, J., Sapp, M., Schiller, J., Thoresen, S., Wang, Z., Youngman, L. and Dillner, J.: A prospective, seroepidemiological study of the role of Human Papillomavirus in esophageal cancer in Norway. Cancer Res. 57: 3989–3992 (1997)
8. Dillner, J., Knekt, P., Boman, J., Lehtinen, M., af Geijersstam, V., Sapp, M., Schiller, J., Maatela, J. and Aromaa, A.: Seroepidemiological association between human-papillomavirus infection and risk of prostate cancer. Int. J. Cancer. 75: 564–567 (1998)
9. af Geijersstam, V., Kibur, M., Wang, Z., Koskela, P., Pukkala, E., Schiller, J., Lehtinen, M. and Dillner, J.: Stability over time of serum antibody levels to Human Papillomavirus type 16. J. Infect. Dis. 177: 1710–1714 (1998)
10. Luostarinen, T., af Geijersstam, V., Bjørge, T., Eklund, C., Hakama, M., Hakulinen, T., Jellum, E., Koskela, P., Paavonen, J., Pukkala, E., Schiller, J.T., Thoresen, S., Youngman, L.D., Dillner, J. and Lehtinen, M.: No excess risk of cervical carcinoma in women seroposi-tive for both HPV16 and HPV6/11. Int. J. Cancer. 80: 818–822 (1999)
11. Lehtinen, M., Luostarinen, T., Youngman, L.D., Anttila, T., Dillner, J., Hakulinen, T., Koskela, P., Lenner, P. and Hallmans, G.: Low levels of serum vitamins A and E in blood and subsequent risk for cervical cancer: interaction with HPV seropositivity. Nutr. Cancer. 34: 229–234 (1999)
12. Kibur, M., af Geijerstamm, V., Pukkala, E., Koskela, P., Luostarinen, T., Paavonen, J., Schiller, J., Wang, Z., Dillner, J. and Lehtinen, M.: Attack rates of Human Papillomavirus type 16 and cervical neoplasia in primiparous women and field trial designs for HPV16 vaccination. Sex. Transm. Infect. 76: 13–17 (2000)
13. Koskela, P., Anttila, T., Bjørge, T., Brunsvig, A., Dillner, J., Hakama, M., Hakulinen, T., Jellum, E., Lehtinen, M., Lenner, P., Luostarinen, T., Pukkala, E., Saikku, P., Thoresen, S., Youngman, L. and Paavonen, J.: Chlamydia trachomatis infection as a risk factor for invasive cervical cancer. Int. J. Cancer. 85: 35–39 (2000)
14. Sigstad, E., Lie, A.K., Luostarinen, T., Dillner, J., Jellum, E., Lehtinen, M., Thoresen, S. and Abeler, V.: A prospective study of the relationship between prediagnostic Human Papillomavirus seropositivity and HPV DNA in subsequent cervical carcinomas. Br. J. Cancer. 87: 175–180 (2002)
15. Mork, J., Lie, A. K., Glattre, E., Hallmans, G., Jellum, E., Koskela, P., Møller, B., Pukkala, E., Schiller, J.T., Youngman, L., Lehtinen, M. and Dillner, J.: Human Papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N. Engl. J. Med. 344: 1125–1131 (2001)
16. Anttila, T., Saikku, P., Koskela, P., Bloigu, A., Dillner, J., Ikäheimo, I., Jellum, E., Lehtinen, M., Lenner, P., Hakulinen, T., Närvänen, A., Pukkala, E., Thoresen, S., Youngman, L. and Paavonen, J.: Serotypes of Chlamydia trachomatis and risk for development of cervical squamous cell carcinoma. JAMA. 285: 47–51 (2001)
17. Stattin, P., Adlercreutz, H., Tenkanen, L., Jellum, E., Lumme, S., Hallmans, G., Harvei, S., Teppo, L., Stumpf, K., Luostarinen, T., Lehtinen, M., Dillner, J. and Hakama, M.: Circulating enterolactone and prostate cancer risk: a Nordic nested case-control study. Int. J. Cancer. 99: 124–129 (2002)
18. Bjørge, T., Engeland, A., Luostarinen, T., Mork, J., Gislefoss, R.E., Jellum, E., Koskela, P., Lehtinen, M., Pukkala, E., Thoresen, S.Ø. and Dillner, J.: Human Papillomavirus infection as a risk factor for anal and perianal skin cancer in a prospective study. Br. J. Cancer. 87: 61–64 (2002)
19. Stattin, P., Lumme, S., Tenkanen, L., Alfthan, H., Jellum, E., Hallmans, G., Thoresen, S., Hakulinen, T., Luostarinen, T., Lehtinen, M., Dillner, J., Stenman, U-H. and Hakama, M.: High levels of circulating testosterone are not associated with in creased prostate cancer risk: a pooled prospective study. Int. J. Cancer. 108: 418–424 (2004)
20. Lehtinen, M., Koskela, P., Jellum, E., Bloigu, A., Anttila, T., Hallmans, G., Luukkaala, T., Thoresen, S., Youngman, L., Dillner, J. and Hakama, M.: Herpes simplex virus and risk of cervical cancer: a longitudinal nested case-control study in the Nordic countries. Am. J. Epidemiol. 156: 687–692 (2002)
21. Lehtinen, M., Pawlita, M., Zumbach, K., Lie, K., Hakama, M., Jellum, E., Koskela, P., Luostarinen, T., Paavonen, J., Pukkala, E., Sigstad, E., Thoresen, S. and Dillner, J.: Evaluation of antibody response to human papillomavirus early proteins in women in whom cervical cancer developed 1 to 20 years later. Am. J. Obstet. Gynecol. 188: 49–55 (2003)
22. Kapeu, A.S., Luostarinen, T., Jellum, E., Dillner, J., Hakama, M., Koskela, P., Lenner, P., Löve, A., Mahlamaki, E., Thoresen, S., Tryggvadóttir, L., Wadell, G., Youngman, L., Lehtinen, M.: Is smoking an independent risk factor for invasive cervical cancer? A nested case-control study within Nordic biobanks. Am J Epidemiol. 169: 480–8 (2009)
23. Paavonen, J., Karunakaran, K.P., Noguchi, Y., Anttila, T., Bloigu, A., Dillner, J., Hallmans, G., Hakulinen, T., Jellum, E., Koskela, P., Lehtinen, M., Thoresen, S., Lam, H., Shen, C. and Brunham, R.C.: Serum antibody response to the heat shock protein 60 of Chlamydia trachomatis in women with developing cervical cancer. Am. J. Obstet. Gynecol. 189: 1287–1292 (2003)
24. Lehtinen, M., Koskela, P., Ögmundsdóttir, H.M., Bloigu, A., Dillner, J., Gudnadóttir, M., Hakulinen T., Kjartansdóttir, A., Kvarnung, M., Pukkala, E., Tulinius, H. and Lehtinen, T.: Maternal Herpesvirus infections and risk of acute lymphoblastic leukemia in the offspring. Am. J. Epidemiol. 158: 207–213 (2003)
25. Tuohimaa, P., Tenkanen, L., Ahonen, M., Lumme, S., Jellum, E., Hallmans, G., Stattin, P., Harvei, S., Hakulinen, T., Luostarinen, T., Dillner, J., Lehtinen, M. and Hakama, M.: Both high and low levels of blood vitamin D are associated with a higher prostate cancer risk: a longitudinal, nested case-control study in the Nordic countries. Int. J. Cancer. 108: 104–108 (2004)
26. Luostarinen, T., Lehtinen, M., Bjørge, T., Abeler, V., Hakama, M., Hallmans, G., Jellum, E., Koskela, P., Lenner, P., Lie, A. K., Paavonen, J., Pukkala, E., Saikku, P., Sigstad, E., Thoresen, S., Youngman, L.D., Dillner, J. and Hakulinen, T.: Joint effects of different Human Papillomaviruses and Chlamydia trachomatis infections on risk of squamous cell carcinoma of the cervix uteri. Eur. J. Cancer. 40: 1058–1065 (2004)
27. Lehtinen, M., Ögmundsdóttir, H.M., Bloigu, A., Gudnadóttir, M., Hakulinen, T., Hemminki, E., Kjartansdóttir, A., Paavonen, J., Pukkala, E., Tulinius, H., Lehtinen, T. and Koskela, P.: Associations between three types of maternal bacterial infection and risk of leukemia in the offspring. Am. J. Epidemiol. 162: 662–667 (2005)
28. Anttila, T., Tenkanen, L., Lumme, S., Leinonen, M., Gislefoss, R.E., Hallmans, G., Thoresen, S., Hakulinen, T., Luostarinen, T., Stattin, P., Saikku, P., Dillner, J., Lehtinen, M. and Hakama, M.: Chlamydial antibodies and risk of prostate cancer. Cancer Epidemiol. Biomarkers Prev. 14: 385–389 (2005)
29. Stolt, A., Kjellin, M., Sasnauskas, K., Luostarinen, T., Koskela, P., Lehtinen, M. and Dillner, J.: Maternal Human Polyomavirus infection and risk of neuroblastoma in the child. Int. J. Cancer. 113: 393–396 (2005)
30. Hakama, M., Luostarinen, T., Hallmans, G., Jellum, E., Koskela, P., Lehtinen, M., Thoresen, S., Youngman, L. and Hakulinen, T.: Joint effect on HPV16 with Chlamydia trachomatis and smoking on risk of cervical cancer: antagonism or misclassification (Nordic countries). Cancer Causes Control. 11: 783–790 (2000)
31. Tedeschi, R., Bidoli, E., Agren, Å., Wadell, G., De Paoli, P. and Dillner, J.: Epidemiology of Kaposi’s sarcoma herpesvirus (HHV8) in Västerbotten county, Sweden. J. Med. Virol. 78: 372–378 (2006)
32. Tedeschi, R., Luostarinen, T., De Paoli, P. Gislefoss, R.E., Tenkanen, L., Virtamo, J., Koskela, P., Hallmans, G., Lehtinen, M. and Dillner, J.: Joint Nordic prospective study on human herpesvirus 8 and multiple myeloma risk. Br. J. Cancer 93: 834–837 (2005)
33. Korodi, Z., Dillner, J., Jellum, E., Lumme, S., Hallmans, G., Thoresen, S., Hakulinen, T., Stattin, P., Luostarinen, T., Lehtinen, M. and Hakama, M.: Human papillomavirus 16, 18, and 33 infections and risk of prostate cancer: a Nordic nested case-control study. Cancer Epidemiol. Biomarkers Prev. 14: 2952–2955 (2005)
34. Pukkala, E., Andersen, A., Berglund, G., Gislefoss, R., Gudnason, V., Hallmans, G., Jellum, E., Jousilahti, P., Knekt, P., Koskela, P., Kyyronen, P. P., Lenner, P., Luostarinen, T., Love, A., Ogmundsdottir, H., Stattin, P., Tenkanen, L., Tryggvadottir, L., Virtamo, J., Wadell, G., Widell, A., Lehtinen, M. and Dillner, J.: Nordic biological specimen banks as basis for studies of cancer causes and control – more than 2 million sample donors, 25 million person years and 100,000 prospective cancers. Acta Oncol. 46: 286–307 (2007)
35. ATBC (The Alpha-Tocopherol B-CCPSG): The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N. Engl. J. Med. 330: 1029– 1035 (1994)
36. Meurman, L.O., Pukkala, E. and Hakama, M.: Incidence of cancer among anthophyllite asbestos miners in Finland. Occup. Environ. Med. 51: 421–425 (1994)
37. Pukkala, E. (1995) Cancer risk by social class and occupation. A survey of 109,000 cancer cases among Finns of working age. Contributions to Epidemiology and Biostatistics. Basel: Karger; 7
38. Liu, Q., Wuu, J., Lambe, M., Hsieh, S.F., Ekbom, A. and Hsieh, C.C.: Transient increase in breast cancer risk after giving birth: postpartum period with the highest risk (Sweden). Cancer Causes Control. 13: 4, 299–305 (2002)
39. Andersen, A., Barlow, L., Engeland, A., Kjaerheim, K., Lynge, E. and Pukkala, E.: Work-related cancer in the Nordic countries. Scand. J. Work Environ. Health. 25, Suppl. 2 (1999)
40. Malila, N., Virtanen, M.J., Jarmo Virtamo, J., Albanes, D. and Pukkala, E.: Cancer incidence in a cohort of Finnish male smokers. Eur. J. Cancer Prev. 15: 103–107
41. Dreyer, L., Winther, J.F., Pukkala, E. and Andersen, A.: Tobacco smoking. APMIS, 105, Suppl. 76: 9–47 (1997)
42. Lehtinen, M., Leminen, A., Kuoppala, T., Tiikkainen, M., Lehtinen, T., Lehtovirta, P., Punnonen, R., Vesterinen, E. and Paavonen, J.: Pre-and post-treatment serum antibody responses to HPV16 E2 and HSV-2 ICP8 proteins in women with cervical carcinoma. J. Med. Virol. 37: 180–186 (1992)
43. Lehtinen, M., Hakama, M., Knekt, P., Heinonen, P.K., Lehtinen, T., Paavonen, J., Teppo, L. and Leinikki, P.: Serum antibodies to the HSV-2 specified major DNA-binding protein are elevated before the diagnosis of cervical cancer. J. Med. Virol. 27: 131–136 (1989)
44. Wallin, K.L., Wiklund, F., Luostarinen, T., Hallmans, G., Anttila, T., Koskela, P., Lehtinen, M., Paavonen, J., Stendahl, U., Wadell, G. and Dillner, J.: Chlamydia trachomatis infection: a risk factor in cervical cancer development – a population based prospective study. Int. J. Cancer. 101: 371–374 (2002)
45. Clarce, R., Shipley, M., Lewington, S., Youngman, L., Collins, R., Marmot, M. and Peto, R. Underestimation of risk associations due to regressios dilution in long-term follow-up of prospective studies. Am. J. Epidemiol. 150: 341–353 (1999)
46. Parish, S., Collins, R., Peto, R., Youngman, L., Barton, J., Jayne, K., Clarke, R., Appleby, P., Lyon, V., Cederholm-Williams, S., Marshall, J. and Sleight, P.: Cigarette smoking, tar yields, and non-fatal myocardial infarction: 14,000 cases and 32,000 controls in the United Kingdom. The International Studies of Infarct Survival (ISIS) Collaborators. Br. Med. J. 311: 471–477 (1995)
47. Jellum, E., Andersen, A., Lund-Larsen, P., Theodorsen, L. and Orjasaeter, H.: Experiences of the Janus Serum Bank in Norway. Environ. Health Perspect. 103, Suppl. 3: 85–88 (1995)
48. Pukkala, E. Use of record linkage in small-area studies. In: Elliot, P., Guzick, J., English, D., Stern, R., eds. (1992) Geographical and environmental epidemiology. Oxford: Oxford University Press: 125–131
49. Teppo, L., Pukkala, E. and Lehtonen, M.: Data quality and quality control of a population-based cancer registry. Acta Oncol. 33: 365–369 (1994)
50. Pukkala, E. and Weiderpass, E.: Time trends in socio-economic differences in incidence rates of cancers of the breast and female genital organs (Finland 1971–1995). Int. J. Cancer. 81: 56–61 (1999)
51. Langholz, B. Entries: case-cohort study and case-control sudy, nested. In: Armitage, P., Colton, T., eds. (1999) Encyclopedia of biostatistics. Chichester: John Wiley & Sons: 497–503 & 514–519
52. Greenland, R. and Thomas, D.C.: On the need for the rare disease assumption in case-control studies. Am. J. Epidemiol. 116: 547–553 (1982)
53. Rothman, K.J. and Greenland, S. (1998) Modern Epidemiology 2nd ed. Philadelphia: Lippincott-Raven: 95–96
54. Rundle, A.G., Vineis, P. and Ahsan, H.: Design options for molecular epidemiology research within cohort studies. Cancer Epidemiol. Biomark. Prev. 14: 1899–1907 (2005)
55. Riboli, E., Hunt, K.J., Slimani, N., Ferrari, P., Norat, T., Fahey, M., et al.: European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr. 5: 1113–1124 (2002)
56. Wacholder, S., Silverman, D.T., McLaughlin, J.K. and Mandel, J.S.: Selection of controls in case-control studies. III. Design options. Am. J. Epidemiol. 135: 1042–1050 (1992)
57. Pukkala, E., Söderman, B., Okeanov, A., Storm, H., Rahu, M., Hakulinen, T., Becker, N., Stabenow, R., Bjarnadottir, K., Stengrevics, A., Gurevicius, R., Glattre, E., Zatonski, W., Men, T. and Barlow, L. (2001) Cancer atlas of Northern Europe. Cancer Society of Finland Publication No. 62, Helsinki (69 pages + CD)